Blocking a specific mitochondrial channel to improve obesity and liver health
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD
['FUNDING_R01'] · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · NIH-11004278
This study is looking at how blocking a specific channel in our cells that helps manage magnesium might change how our bodies handle sugar and fat, which could help people with obesity and fatty liver disease find better treatments.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER (nih funded) |
| Locations | 1 site (SAN ANTONIO, UNITED STATES) |
| Trial ID | NIH-11004278 on ClinicalTrials.gov |
What this research studies
This research investigates how blocking the mitochondrial Mg2+ channel, known as Mrs2, can influence metabolism in conditions like obesity and nonalcoholic fatty liver disease (NAFLD). By using advanced techniques such as CRISPR/Cas9 to create models that lack this channel, the researchers aim to understand its role in glucose and lipid metabolism. The study will explore how changes in magnesium dynamics affect energy expenditure and fat storage in the body, potentially leading to new treatment strategies for metabolic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from obesity, type 2 diabetes, or nonalcoholic fatty liver disease.
Not a fit: Patients with metabolic disorders not related to obesity or liver health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve metabolic health and reduce the risk of obesity-related diseases.
How similar studies have performed: While the specific approach of targeting the Mrs2 channel is novel, related research has shown promising results in understanding the role of mitochondrial dynamics in metabolic diseases.
Where this research is happening
SAN ANTONIO, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER — SAN ANTONIO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUNISWAMY, MADESH — UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- Study coordinator: MUNISWAMY, MADESH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adult onset diabetes, Adult-Onset Diabetes Mellitus